Observational studyUnited European gastroenterology journal2020

Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease.

Iago Rodríguez-Lago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.